title: COPD in 2016: some answers, more questions.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5360, USA.
authors.forename: Wassim W
authors.initials: WW
authors.lastname: Labaki
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5360, USA.
authors.forename: Carlos H
authors.initials: CH
authors.lastname: Martinez
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5360, USA. Electronic address: mrking@umich.edu.
authors.forename: MeiLan K
authors.initials: MK
authors.lastname: Han
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D005541:Forced Expiratory Volume; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014797:Vital Capacity
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018727:Muscarinic Antagonists